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Abstract
Understanding the earliest molecular events during nucleation of the amyloid aggregation cascade is of fundamental
significance to prevent amyloid related disorders. We report here an experimental kinetic analysis of the amyloid
aggregation of the N47A mutant of the a-spectrin SH3 domain (N47A Spc-SH3) under mild acid conditions, where it is
governed by rapid formation of amyloid nuclei. The initial rates of formation of amyloid structures, monitored by thioflavine
T fluorescence at different protein concentrations, agree quantitatively with high-order kinetics, suggesting an
oligomerization pre-equilibrium preceding the rate-limiting step of amyloid nucleation. The curves of native state
depletion also follow high-order irreversible kinetics. The analysis is consistent with the existence of low-populated and
heterogeneous oligomeric precursors of fibrillation that form by association of partially unfolded protein monomers. An
increase in NaCl concentration accelerates fibrillation but reduces the apparent order of the nucleation kinetics; and a
double mutant (K43A, N47A) Spc-SH3 domain, largely unfolded under native conditions and prone to oligomerize, fibrillates
with apparent first order kinetics. On the light of these observations, we propose a simple kinetic model for the nucleation
event, in which the monomer conformational unfolding and the oligomerization of an amyloidogenic intermediate are
rapidly pre-equilibrated. A conformational change of the polypeptide chains within any of the oligomers, irrespective of
their size, is the rate-limiting step leading to the amyloid nuclei. This model is able to explain quantitatively the initial rates
of aggregation and the observed variations in the apparent order of the kinetics and, more importantly, provides crucial
thermodynamic magnitudes of the processes preceding the nucleation. This kinetic approach is simple to use and may be
of general applicability to characterize the amyloidogenic intermediates and oligomeric precursors of other disease-related
proteins.
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Introduction
Protein amyloid aggregation is intimately associated with a wide
range of disorders, among which there are some devastating
human diseases such as Alzheimer’s, Huntington’s, Parkinson’s,
prion diseases or type II diabetes [1]. Protein aggregation is also a
general problem in biotechnological applications of proteins and in
some cases plays a biologically relevant role, such as for instance in
the polymerization of actin [2]. For these reasons, experimental
kinetics studies of protein aggregation have been of general interest
since several decades ago [3]. Quantitative aggregation kinetics
analysis can help to infer the detailed mechanism and provide
insight into the identity and properties of key intermediates in the
aggregation pathway. Understanding the mechanisms of protein
aggregation is a key step to control protein aggregation and to
delineate effective therapeutic strategies for protein aggregation
disorders.
An increasingly large body of experimental and theoretical
examples of protein aggregation kinetic studies can be found in the
recently reviewed literature [4,5]. Theoretical models usually treat
protein aggregation as a multi-stage process, in which a number of
consecutive and/or parallel stages occur to convert the soluble
protein monomer to large amyloid aggregates [4]. These stages
may include partial unfolding or refolding, oligomerization,
conformational conversion, elongation, condensation, fragmenta-
tion, etc. The broad diversity of proposed models of aggregation
can be understood in terms of a predominance of one or more of
these stages in the overall aggregation kinetics, which results in a
variety of kinetic behaviors, depending on the protein and/or the
experimental conditions studied in each case [6].
Almost invariably, the formation of oligomeric species, normally
soluble and sometimes structurally unstable or metastable, is a key
step in the nucleation of amyloid structures. For example, the 40-
or 42-residue forms of amyloid-beta peptide (Abeta) give rise to
different oligomeric species with a relatively disordered structure in
rapid equilibrium with the monomeric forms [7,8]. Likewise,
similar oligomers featuring dynamic structures have been identi-
fied during amyloid fibril formation of the yeast prion Sup35p,
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phosphoglycerate kinase or the SH3 domain of the PI3 kinase [9–
11]. Nucleation is then completed by structural conversion of these
intermediate species into small amyloid-like structures that act
subsequently as templates triggering rapid growth of fibrils.
Sometimes, native or native-like structures are forming the
oligomeric aggregates and then conversion to amyloid structures
takes place within the aggregates [12,13].
The investigation of the mechanism of formation of soluble
oligomers during the initial stages of aggregation is of vital
importance because these species appear to constitute the main
toxic agents in neurodegenerative diseases [14]. Supporting this
hypothesis, a significant correlation was found between the levels
of soluble Abeta peptide, including its oligomeric forms, and the
degree of synaptic alteration, neurodegeneration and cognitive
decline in Alzheimer’s disease patients, whereas a similar
correlation was not observed for the insoluble deposits [15]. Also
for a-synuclein, increasing evidence suggests that non-fibrillar
dimers or oligomers play a major role in the progress of
Parkinson’s disease [16]. Similarly, it has been shown with
neuronal cell cultures that there is less cell death in the presence
of large aggregates of poly-Q-rich Huntingtin than when the
soluble fraction is present [17]. Certain non-fibrillar aggregates of
transthyretin have also been shown to be toxic to neuronal cells
under the conditions where the native tetramers and the mature
fibrils have no significant toxicity [18].
The general toxic nature of prefibrillar aggregates has been
further underlined by the finding that oligomeric species of
proteins unrelated to disease, such as HypF-N from E. coli, the
SH3 domain of PI3 kinase or equine lysozyme, are highly toxic in
fibroblast and neuron cultures, whereas the amyloid fibrils of the
same proteins show low toxicity [19,20]. These and many other
studies have emphasized on the importance of using well-
characterized model proteins, even unrelated to disease, to
investigate the mechanisms of amyloid aggregation.
In previous work, we have reported that the wild type form and
several mutants of the SH3 domain of a-spectrin (Spc-SH3) are
rapidly converted to amyloid fibrils at mild acid pH [21,22]. We
found that the rate of nucleation is strongly affected by sequence
mutations and experimental conditions, in particular temperature,
pH and the concentrations of protein and salt, resulting in
considerable changes in the governing kinetics and also in the
morphological properties of the finally assembled fibrils [23]. For
instance, at low salt concentration the aggregation shows a
considerable lag phase, as usually observed for nucleation-
dependent polymerization, resulting in well-ordered straight and
twisted amyloid fibrils. An increase in salt concentration removes
the lag phase due to an increase in the rate of nucleation, which is
no longer rate-limiting in the formation of fibrils. Under these
conditions, a higher accumulation of amyloid nuclei results in
curly and relatively disordered fibrils. Salt ions appear to act by
lowering the apparent activation energy of fibril nucleation [23].
These results implied that the molecular events taking place prior
to and during the nucleation of amyloid structures determine the
fate of the protein chain along the subsequent aggregation
cascade. Therefore, a more detailed knowledge of the molecular
mechanism of nucleation could give additional insight upon the
physicochemical factors governing the process and offer more
opportunities to its manipulation and control.
In this work we analyzed quantitatively the kinetics of formation
of amyloid nuclei of the N47A Spc-SH3 mutant using a range of
biophysical techniques. Although most amyloid fibrillation studies
with both disease-related and unrelated proteins have observed
significant lag phases in the kinetics, typical of nucleation-
dependent processes, during these lag phases the formation of
amyloid nuclei is a rare process, difficult to observe experimen-
tally, and the aggregation kinetics are mainly governed by the
elongation of few preformed nuclei accompanied by other
secondary processes. For this reason, we decided to work under
conditions of fast nucleation, i.e., in the absence of a lag phase, so
that amyloid nuclei are abundantly formed and the observed
kinetics are mainly representative of the nucleation process itself,
whereas subsequent processes such as fibril elongation or
fragmentation can be neglected during the initial stages of the
kinetics. Under the selected conditions the nucleation kinetics can
be quantitatively described as an irreversible high-order reaction,
suggesting that nucleation of amyloid structures is preceded by
formation of oligomeric precursors in rapid equilibrium with the
monomer. Using a battery of biophysical methods we showed that
these oligomers occur at very low population, have a heteroge-
neous size and form by rapid association of partially unfolded
protein monomers. We proposed a mathematical kinetic model in
which stable amyloid nuclei form by a conformational change of
the protein within the oligomers. The model explained very well
the observed initial rates of aggregation and allowed us to derive
thermodynamic magnitudes characterizing the amyloidogenic
intermediate and its oligomerization, as well as the rate constants
of conformational change that forms the amyloid nuclei.
Materials and Methods
Protein sample preparation
The Spc-SH3 domain mutants studied were overexpressed in E.
coli and purified as described elsewhere [24]. 15N-labelled protein
was produced in E. coli cultures using M9 minimal media with
15N-ammonium sulfate as the sole nitrogen source. For aggrega-
tion experiments the lyophilized protein was dissolved, unless
stated, in the appropriate buffer at 4uC, centrifuged for 2 minutes
and filtered through a 0.2 mm filter. Protein concentration was
determined by measurement of absorbance at 280 nm using an
extinction coefficient of 15220 M21 cm21.
ThT and ANS fluorescence
Thioflavine T (ThT) or 1-Anilino-8-naphthalene sulfonate
(ANS) fluorescence was continuously monitored during amyloid
fibril formation at 37uC in a Varian Cary Eclipse spectrofluorim-
eter (Agilent Technologies, Santa Clara, CA) equipped with a
Peltier-controlled thermostatic cell holder. To start aggregation, a
freshly prepared protein solution was mixed with a concentrated
stock solution of each dye previously prepared in the same buffer
(100 mM glycine, pH 3.2, 100 mM NaCl). The sample was then
placed into a fluorescence cuvette, which was previously thermo-
statized at 37uC, and covered with mineral oil to avoid
evaporation. Fluorescence intensity of ThT at 10 mM was
monitored at 485 nm using an excitation wavelength of 440 nm
and the ANS fluorescence was measured at 470 nm with
excitation at 370 nm using various ANS concentrations. Previous
control experiments allowed us to establish the appropriate
concentration of each dye for the experiments. A linear
relationship between the ThT fluorescence and the mass amount
of amyloid fibrils was established using preformed amyloid fibrils
(Figure S1).
Initial rates of growth of amyloid structure were calculated by
fitting the initial region of the ThT kinetics curves, corresponding
to an approximate signal growth of less than 50% of the
maximum, using a double exponential function:
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This operational extrapolation procedure allowed us an accurate
determination of the initial slopes of the ThT curves and avoided
the assumption of any time interval in the kinetics to define an
initial aggregation rate.
Circular dichroism (CD)
CD measurements were made in a Jasco J-715 spectropolarim-
eter (Tokyo, Japan) equipped with a thermostatic cell holder. Near
UV CD spectra of the native N47A Spc-SH3 domain and the
preformed amyloid fibrils were acquired at 4uC between 260 nm
and 320 nm at a protein concentration of 8 mg mL21 in a 1 mm
path length cuvette (Figure S2). This short path length was
necessary to avoid instrument saturation due to the high protein
concentration of the samples. Far-UV CD measurements with the
K43A-N47A double mutant were done at a protein concentration
of 0.2 mg mL21using a 1 mm path length cuvette. For kinetic
experiments monitored by near-UV CD, a fresh protein sample
was placed into a 1 or 2 mm cuvette, depending on the protein
concentration of the experiment. The CD signal at 295 nm was
then monitored at 37uC during the time course of aggregation.
Data were averaged for 20 s using a band width of 1 nm and a
response time of 4 s.
Nuclear Magnetic Resonance
To follow the amyloid aggregation by two-dimensional NMR in
real time, 4 mg of 15N-labelled protein was dissolved in 500 mL of
cold buffer (100 mM d6-Gly, 100 mM NaCl, pH* 3.2) containing
10% D2O and placed into the NMR tube. The final protein
concentration was 1.1 mM (8 mg mL21). The temperature in the
NMR probe was set to 37uC and, immediately after temperature
equilibration, a series of 1H-15N HSQC two-dimensional spectra
were acquired during the time course of aggregation in a
600 MHz Varian NMRsystem spectrometer (Agilent Technolo-
gies, Santa Clara, CA). Each spectrum consisted of 512632
complex points recorded using a relaxation delay of 1 s and
resulting in a total experiment time of 2 minutes and 28 seconds.
The spectral widths were 12.04 ppm for 1H and 30.00 ppm for
15N. Spectra were processed using NMRPipe [25]. The assign-
ment of the 1H-15N crosspeaks of the HSQC spectrum was
performed using as a reference the previously published assign-
ment of the WT Spc-SH3 domain [26]. To obtain the aggregation
kinetics, the signal intensities were evaluated using NMRview [27]
and represented versus the incubation time.
Dynamic light scattering (DLS)
Aggregation was monitored at 37uC by DLS in a DynaPro MS-
X instrument (Wyatt, Santa Barbara, CA, USA) using a
thermostatized 30 mL quartz cuvette. The protein solution and
the buffer were centrifuged and filtered through a 0.02 mm filters
before the measurements. During the time course of the
aggregation the DLS data were acquired every 45 seconds until
saturation of the signal. The laser power was adjusted to avoid
early saturation. Dynamics v.6 software was used in data collection
and processing of the correlation function to finally obtain the
particle size distributions during the course of aggregation.
Attenuated total reflectance Fourier-transform infrared
(ATR-FTIR) spectroscopy
Infrared spectra were recorded from 4000 cm21 to 900 cm21
on a Bruker IFS-66 FTIR spectrophotometer (Brucker, Ettlingen,
Germany) equipped with a BioATR-II cell. For each sample, 128
interferograms were coadded and Fourier transformed with a zero
filling factor of 4 to yield spectra with a nominal resolution of
2 cm21. The sample temperature was controlled and set to 37uC
by means of a thermostatic cell jacket. FTIR measurements were
taken at 37uC every 90 seconds for the first 120 minutes of
incubation and thereafter every 30 minutes. Buffer spectra were
recorded under identical conditions and subtracted from the
spectra of the protein sample (Figure S3). Spectral contributions
from residual water vapor were reduced using the atmospheric
compensation filter built in the Bruker OPUS software. Difference
FTIR spectra were then calculated by subtracting the first
measurement from all subsequent spectra. The change in the
area of the difference band (from 1635 cm21 to 1591 cm21) was
calculated and plotted versus time.
Differential scanning calorimetry
The thermal unfolding of the K43A-N47A Spc-SH3 double
mutant was monitored in a Auto-Cap VP-DSC instrument
(Microcal, Northampton, MA) at a scan rate of 1.5uC min21
and a protein concentration of about 1 mg mL21. The molar
partial heat capacity curve (Cp) was calculated from the DSC data
and analyzed using Origin 6.1 (OriginLab, Northampton, MA)
according to the two-state unfolding model.
Size-exclusion chromatography
Size-exclusion chromatography (SEC) experiments were per-
formed at 37uC using a thermostatized Superdex 75 HR 10/30
column connected to an ÄKTA prime plus FPLC chromatograph
(GE Healthcare, Tokyo). N47A Spc-SH3 samples were prepared
in the aggregation buffer at the appropriate concentration and
were incubated at 37uC in a water bath during different times.
The same buffer was used for the elution at a flow rate of
1 mL min21. A volume of 100 mL was loaded onto the column.
The elution profiles were recorded by monitoring the absorbance
at 280 nm. The column was previously calibrated using protein
standards.
Results
Kinetics of formation of amyloid structure observed by
thioflavine T fluorescence
The kinetics of growth of amyloid fibrils of N47A Spc-SH3 was
followed at 37uC at several protein concentrations by continuously
monitoring ThT fluorescence at pH 3.2 in 100 mM glycine buffer,
100 mM NaCl. Under these experimental conditions, the
development of amyloid structures takes place very rapidly
without any significant lag phase, indicating a fast formation of
amyloid nuclei (Figure 1A). No stirring or shaking of the samples
was necessary to obtain rapid and reliable aggregation kinetics and
we observed no significant sedimentation of the aggregates during
the length of our experiments. This allowed us monitoring directly
the aggregation kinetics using a variety of biophysical techniques,
avoiding irreproducibility arising from the control of stirring.
Heterogeneous Oligomers as Amyloid Precursors
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The appearance of a significant amount of fibrils visible by
electron microscopy is delayed under these conditions for at least
30 min (see Figure 10 in ref. [21]). Therefore, initial growth of
ThT fluorescence could be attributed to the formation of small
amyloid nuclei. The aggregation process does not follow first-order
kinetics and its rate is strongly dependent of the initial
concentration of protein. In addition, the ThT signal does not
reach a plateau within the time of the experiments. Initial rates of
formation of amyloid nuclei were estimated from initial slopes of
the kinetic traces as described in Material and Methods. Using a
double logarithmic plot, we found that the initial rates scale
approximately with the fourth power of the initial protein
concentration, indicating a high order for the nucleation of
amyloid structure (Figure 1B, Table 1). Nevertheless, there is a
slight but significant sigmoidal shape in this plot.
Kinetics of depletion of native protein
We monitored the aggregation under the same experimental
conditions by acquiring a series of 15N-1H HSQC NMR
experiments during the course of the fibrillation process at 37uC
using a 1.1 mM (8 mg mL21) sample of 15N-labelled protein. This
experiment was aimed at the detection of any early soluble
intermediates of the protein, which may become populated prior
to the formation of the fibrils. All spectra looked, however,
identical to that of the native protein except for a rapid and
continuous decrease in intensity (Figure S4). No significant shifts of
the HSQC signals were observed during the whole process and the
intensity decays of all the signals are virtually identical. These
observations may suggest that the native protein is converted to
large aggregates without accumulation of any intermediate visible
by NMR. It is possible that interconversion of intermediates taking
place in the NMR time scale could result in extreme line
broadening, which renders invisible the signals. A plot of the
normalized and averaged intensities of all the native HSQC peaks
does not follow a single exponential decay (Figure 2). The kinetics





Where n is the apparent order of the reaction, C0 is the initial
protein concentration, [N] is the concentration of native protein at
time t and k is an apparent n-order rate constant. This fitting
resulted in an apparent order of 4.2 6 0.3 (Table 1).
The rate of disappearance of the native protein during the early
stages of fibrillation was also monitored by near-UV CD at several
protein concentrations ranging between 0.84 mM and 1.6 mM
(Figure 3). In these experiments we took advantage of the absence
of CD signal at 295 nm in the near-UV CD spectrum of the
amyloid fibrils and we could assume therefore that the CD signal
intensity at this wavelength is proportional to the concentration of
the native protein monomer during the aggregation process. The
kinetic curves are strongly concentration-dependent and in
agreement with a high-order process. When normalized by the
protein concentration, as expected for this type of kinetics, the
curves converge approximately to a common trend. Global fitting
of all the kinetic curves using equation 3 did not give fully
satisfactory results especially for the curves at the lowest protein
concentrations. Individual fittings yielded apparent orders ranging
between 4 and 4.7 and relatively similar values for the apparent
rate constants (Table 1). The initial rates of native state depletion,
estimated by extrapolation of the slopes of the kinetics, are also
strongly dependent on protein concentration. Double logarithmic
plot of the initial rates versus the protein concentration provides an
apparent order of about 6.
These results clearly demonstrate that during the early stages of
aggregation, both the depletion of native protein and the growth of
amyloid structures follow high-order irreversible kinetics. A simple
interpretation of this result would suggest that the precursors of the
rate-limiting step for amyloid nucleation are oligomers of about 4
to 6 protein molecules. Formation of these oligomeric precursor
species from the native state of the protein seems to be therefore a
necessary step preceding the nucleation process. Furthermore, this
oligomerization must be sufficiently fast under these conditions to
avoid a lag phase in the fibrillation.
Formation of b-sheet structure
Infrared spectra were measured during the aggregation process
under the same conditions of the above experiments (Figure S3).
The development of a prominent band at 1622 cm21 indicative of
Figure 1. Kinetics of formation of amyloid fibrils followed by
ThT fluorescence at 376C. A: Kinetic curves of amyloid fibrillation of
N47A Spc-SH3 in the presence of 100 mM NaCl at different initial
protein concentrations as indicated. B: Double logarithmic plot of the
initial rates of amyloid fibrillation of N47A Spc-SH3 versus the initial
protein concentration in presence of different NaCl concentrations:
50 mM (blue); 100 mM (red) and 200 mM (green). The initial rates of the
double mutant K43A-N47A Spc-SH3 in the presence of 100 mM NaCl
are shown in magenta. Symbols correspond to the experimental rates
and continuous lines represent the best fits according to equations 4 to
8 of the model as described in the text.
doi:10.1371/journal.pone.0049690.g001
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the formation of b-sheet structure occurs in a rapid phase within
100–120 min (Figure 4). Further development of b-sheet structure
occurs in a slower process as a result of fibril formation.
The rapid conformational change to achieve beta-sheet
structure was also observed by far-UV CD in a previous work
although these data were presented in a normalized form (mean-
residue molar ellipticity, see Figure 2b in ref. [23]). The negative
CD signal at 215 nm increases very rapidly in a fast phase within
about 100 min, indicating a fast conformational change with b-
sheet formation even at the lowest protein concentration analyzed
(0.36 mM). The initial rates of CD signal development scale
approximately with the 1.5 power of the initial protein concen-
tration, suggesting that the appearance of some b-sheet structure
occurs prior to the fibril nucleation and is likely to be concomitant
to pre-oligomerization. These results clearly indicate the occur-
rence of a rapid conformational phase previous to nucleation of
the amyloid fibrils, which involves partial unfolding of the protein,
formation of b-sheet structure and oligomerization.
Detection of partially-folded species
The formation of oligomers of partially unfolded protein may
result in the exposure of hydrophobic surface, which could be
monitored using ANS fluorescence. We first followed the process
for a protein concentration of 1.26 mM using different ANS
concentrations ranging between 10 mM and 400 mM (not shown).
The ANS fluorescence intensity develops rapidly in all experi-
ments reaching a plateau. The final ANS fluorescence intensity is
approximately proportional to the ANS concentration up to about
Table 1. Kinetic analysis of the apparent order for irreversible aggregation of Spc-SH3 using different biophysical techniques and
methods of analysis.
Method Type of analysis Apparent order log k (M12n min21) Protein concentration (mM)
ThT fluorescence Initial ratesa 3.80 6 0.13 - 0.31–1.44
NMR Non-linear fittingb 4.2 6 0.3 9.2 6 0.6 1.1
Near-UV CD Initial ratesa 6.1 6 0.5 12.9 6 1.4 0.84–1.6
Non-linear fittingb 4.57 6 0.07 9.2 6 0.3 1.6
4.73 6 0.08 9.7 6 0.3 1.4
4.52 6 0.08 8.9 6 0.2 1.18
4.62 6 0.06 9.6 6 0.2 1.14
4.28 6 0.06 7.9 6 0.3 0.95
4.0 6 0.1 6.9 6 0.3 0.84
ANS fluorescence Initial ratesa 3.1 6 0.5 - 0.14–1.17
Far-UV CD Initial ratesa 1.5 6 0.3 - 0.36–1.11
aInitial rates of signal growth were plotted versus the initial protein concentration in a double logarithmic plot. The apparent order is derived from the slope in a linear
fit to this representation.
bThe normalized signal intensity decay was fitted to the integrated equation of an irreversible n-order kinetics.
doi:10.1371/journal.pone.0049690.t001
Figure 2. Kinetics of native-state depletion monitored by NMR.
Averaged and normalized intensities of the cross peaks of all residues of
N7A Spc-SH3 in a series of 15N-1H-HSQC NMR spectra recorded during
the course of aggregation at 37uC using an initial protein concentration
of 1.1 mM. The red continuous line represents the best fit using the
integrated equation of an n-order irreversible kinetics. The inset shows
an expansion of the early times of the kinetics.
doi:10.1371/journal.pone.0049690.g002
Figure 3. Kinetics of native state depletion monitored by near-
UV CD. Different initial protein concentrations of N47A Spc-SH3 were
analyzed as indicated. The intensity of the native CD signal at 295 nm
was monitored as a function of time and normalized using the values of
initial protein concentration.
doi:10.1371/journal.pone.0049690.g003
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100 mM and then tends to saturate. Above 50 mM ANS we found
a significant effect of ANS on the rate of aggregation (results not
shown). Using 25 mM ANS and varying the protein concentration,
we observed considerable dependence of the growth rate of
fluorescence intensity and absence of lag phase (Figure 5). The
growth of ANS fluorescence intensity occurs earlier than that of
ThT fluorescence, indicating rapid exposure of hydrophobic
patches preceding nucleation of amyloid structure. Initial rate
analysis indicates an apparent order of 3.1 6 0.5, which is
intermediate between the order observed for fibrillation and that
of the initial conformational change monitored by far-UV CD.
These results suggest that the development of the ANS fluores-
cence signal is not specific of the appearance of oligomers but it
may also report on the formation of amyloid structures. This is
supported by separate experiments, in which we found that ANS
co-precipitates with the amyloid fibrils indicating strong ANS
binding to amyloid structures (results not shown).
Direct detection of oligomeric species
To investigate the growth rate of aggregates, DLS measure-
ments were performed during the course of the aggregation at
several protein concentrations. Figure 6 shows the time evolution
of the scattering intensity and the apparent hydrodynamic radii
(Rh) of the smallest particles visible in the size distributions. The
changes in the particle size distributions clearly indicate a
progressive conversion of the native protein (detected at the early
times as a peak with apparent radius of about 1.7 nm) into larger
particles (Figure 6A). Growing particles are observed with
apparent radii starting from about 10–20 nm and increasing up
to 30–50 nm, depending on the initial protein concentration,
similarly to that observed for Abeta fibrillation by DLS [28]. In
addition, the peak corresponding to the native Rh shifts up to ca.
2.7 to 3.0 nm, which suggests the association of a few protein
molecules into small oligomers. This shift is considerably delayed
as the protein concentration is reduced indicating a slower
accumulation of oligomers. The delay of oligomerization is
coincident with a similar delay in the growth of scattering intensity
(Figure 6B). The lag in the development of scattering intensity is
not observed in the kinetics monitored by ThT fluorescence at
similar concentrations, which indicates that only small-sized
amyloid particles, likely amyloid nuclei, form at early times in
the kinetics. The fact that the onset of growth in scattering
intensity is concurrent with the oligomerization is suggestive of a
condensation of nuclei as the process dominating the growth of
large amyloid aggregates.
SEC experiments were also made to analyze the mixtures
during the early stages of the fibrillation (Figure 7). Samples of
8 mg mL21 (1.1 mM) of protein were incubated at 37uC for
several time periods and analyzed in a Superdex S75 column
previously equilibrated in the same aggregation buffer and also
thermostatized at 37uC (Figure 7A). The elution profile of a non-
incubated sample shows a single peak eluting at 18.5 mL,
corresponding to the native monomer. After 30 min of incubation,
high-molecular weight particles are already formed eluting at the
exclusion volume of the column. The amount of these aggregates
increases at longer times of incubation while the amount of
monomer decreases concomitantly. These species correspond very
likely to stable protofibrils or fibrils. In contrast, for protein
samples incubated for only 5 min or 10 min there is still no
evidence of formation of the high-molecular weight aggregates and
most of the protein eluted as monomer. There is however a non-
negligible UV absorption in the elution profiles for elution volumes
corresponding to intermediate sized particles, suggesting a low
population of oligomeric species (see Figure 7B). These low-
molecular-weight oligomers cannot be detected at any elution
volume if the SEC analysis of the same samples is made at 4uC or
25uC (not shown), indicating reversibility of the oligomerization at
low temperature. When we repeated the same experiment at 37uC
and double protein concentration (2.2 mM), the presence of small
oligomers is much more evident in the profiles and the formation
of high-molecular weight particles is faster (Figure 7C). There is no
clear peak corresponding to any particular oligomer size but a
broad UV absorption between the monomer and the large
aggregate peaks. This suggests the existence of a distribution of
interconverting oligomers, very likely in equilibrium with the
monomers. Since SEC is a separative technique, the dilution that
Figure 4. Kinetics of formation of beta-sheet structure during
the course of aggregation. Aggregation of N47A Spc-SH3 was
monitored by infrared spectroscopy at different initial protein
concentrations as indicated in the figure. The data correspond to the
area of the spectral band between 1591 cm21 and 1635 cm21 in the
difference spectra obtained by subtracting initial spectrum from that of
each time point of the kinetics.
doi:10.1371/journal.pone.0049690.g004
Figure 5. Exposure of hydrophobic surface during the course
of aggregation of N47A Spc-SH3. Aggregation was monitored by
ANS fluorescence at several initial protein concentrations are indicated
along each curve. The concentration of ANS in these experiments was
50 mM.
doi:10.1371/journal.pone.0049690.g005
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occurs during the chromatography separation would tend to shift
the equilibrium towards the monomer.
From these results, we can conclude that early oligomers form
rapidly during the kinetics leading to the early accumulation of
small amyloid nuclei. The rate of this process is strongly dependent
of the protein concentration and shows apparent high-order
kinetics.
Influence of the salt concentration on the nucleation
kinetics
Previously, we have reported that the concentration of NaCl
strongly affects the nucleation of the N47A Spc-SH3 fibrillation
[23]. Here we re-investigated the effect of the salt concentration on
the nucleation kinetics by measuring the initial rates of fibrillation
at 37uC by ThT fluorescence. Initial rates were measured under
each condition only at protein concentrations producing an
absence of significant lag phase, indicating a fast amyloid
nucleation. As observed before, an increase in NaCl concentration
accelerates the nucleation but, interestingly, reduces the apparent
order of the kinetics from 6.4 6 0.3 at 50 mM NaCl to 3.2 6 0.2
at 200 mM NaCl (Figure 1B, Table 1). This might be in principle
interpreted as a reduction in the average size of the critical
oligomers preceding the nucleation produced by the increase in
the concentration of salt ions. This would be contrary however to
the increase in size of oligomers produced by a rise in the
concentration of NaCl as observed by DLS in our previous work
[23].
A simple nucleation model to interpret initial
aggregation rates
To understand the observed kinetic effects in terms of a
plausible mechanism, we proposed a simple model for amyloid
fibril nucleation. This model is based upon previous polymeriza-
tion models reported in the literature [3,5,6], in which partial
unfolding and/or linear polymerization processes previous to the
rate-limiting steps of aggregation were assumed to be pre-
equilibrated, i.e., they can be considered sufficiently fast to be
under equilibrium during the process. The model is summarized
in Figure 8 and mathematically developed in detail in the
Supporting Information (Text S1):
In this model, N and U are respectively the native and the
unfolded states of the protein. The state I is a monomeric
intermediate prone to intermolecular association in equilibrium
with the folded and unfolded states. The species Ai are oligomeric
aggregates formed by reversible association of intermediate
molecules. There is no limit imposed in our model to the
maximum size of these oligomers, which will be only determined
by the concentration of the associating species and the equilibrium
association constants. The nucleation step was modeled as an
irreversible conformational change of the protein when it is part of
an oligomer, giving rise to an oligomeric amyloid nucleus Fi of the
same size [6]. We did not impose any restriction to the size of the
Figure 6. Time course of aggregation of N47A Spc-SH3
monitored by DLS. Several initial protein concentrations were
analyzed as indicated. A: Hydrodynamic radii of the two smallest
particles visible in the size distributions as a function of the time of
incubation. The sigmoidal lines are used only for clarity purposes. B:
Time dependence of the scattering intensity.
doi:10.1371/journal.pone.0049690.g006
Figure 7. Size-exclusion chromatography analysis of N47A Spc-
SH3 during the course of aggregation. Samples were incubated at
37uC during the times indicated along each elution profile prior to the
analysis. A: Initial protein concentration of 1.1 mM; B: expansion of the
ordinate axis of panel A; C: initial protein concentration of 2.2 mM.
doi:10.1371/journal.pone.0049690.g007
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oligomers that may undergo the nucleation change, except for the
fact that nucleation can only occur from oligomeric states. This is
different to most aggregation models, which usually assume a
unique nucleus size. Since we are specifically modeling the initial
rates of the amyloid nucleation process, we assumed that further
elongation steps are not significant during the very early stages of
the kinetics and do not contribute significantly to the accumulation
of amyloid structures. This assumption is reasonable since we are
extrapolating the aggregation rates to time zero, where no amyloid
nuclei are still formed. In addition, as discussed in the Supporting
Information (Text S3), a significant contribution of monomer
addition to any nuclei or fibrils formed during the early times
would result in upwards curvature of the kinetics, which is not
observed under our experimental conditions, except for very slow
nucleation conditions, such as at low protein and salt concentra-
tion (results not shown).
The equilibrium constants governing the conformational
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We assumed for simplicity that the equilibrium constants of all
oligomerization steps are equal (KA,i = KA) [3]. Using this assump-
tion, it is easy to obtain relatively simple equations relating the
total protein concentration, C0, to the equilibrium constants and
the population of every equilibrium state (see Supplementary
Material). For instance, the fraction of protein in the native state,





Where A = 1+KU, and B = KI?KA?C0. Similarly, the pre-equilibrated
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Here CF stands for the concentration of protein monomers in
amyloid states. kF,i is the first-order rate constant for the
conformational change of an i-sized oligomer to form an amyloid
nucleus of equal size. Also for the sake of simplicity, we assumed
that the rate constants are approximately independent of the size
of the oligomers, i.e. kF,i < kF. Using this assumption eq. 7
becomes:
r0~kF CA,0~
kF BxNð Þ2 2{BxNð Þ
KA 1{BxNð Þ
ð8Þ
According to this equation, the initial slopes of the kinetics of
amyloid growth –for instance, those measured by ThT fluores-
cence– will be a function of the first-order rate constant of
conformational conversion, the initial protein concentration and
the thermodynamic parameters governing the conformational-
association equilibrium preceding the rate-limiting nucleation step.
Using equation 8 we simulated the initial rates of amyloid
nucleation for an extensive set of values of the model parameters.
A summary of the results of these simulations is shown in the
Supporting Information (Text S2). First, we simulated the case
where the amyloidogenic intermediate is the most stable state
under the aggregating conditions (KI..1). In this case there are
two limiting nucleation regimes: A) Low protein concentrations:
C0,,KA
21. Under these conditions the slope of the plot of log r0
vs log C0 is linear with a slope of 2. This means that most of the
protein is in the monomeric state and the nucleation takes place
via the dimer, with apparent 2nd order (I « A2 R F2). B) High
protein concentration: C0..KA
21. In this case, the slope of the
double logarithmic plot is 1 because most of the protein pre-
equilibrates as oligomers and the process simplifies to a first-order
reaction (Ai R Fi). The change from second to first order occurs
progressively when C0 approaches to KA
21.
In the case of a stable folded protein, with a low-populated
amyloidogenic intermediate, there are two similar limiting
regimes: A) Second order for C0,,(KA?KI)
21 and B) first order
for C0..(KA?KI)
21. For protein concentrations around a critical
concentration, C0<(KA?KI)21, the plot of log r0 vs log C0
undergoes an inflexion with a transient increase in slope.
Interestingly, for the same critical concentration, the maximum
slope depends on the relative values of KI and KA, i.e., on the
stability of the monomeric intermediate compared to that of the
oligomers. Low values of KI and high association constant, KA,
give rise to a steep inflexion with high apparent reaction orders.
This is due to a quite pronounced shift in the oligomerization pre-
equilibrium as the protein concentration rises.
Figure 8. Kinetic scheme for amyloid nucleation. N, I and U
represent respectively the native, intermediate and unfolded mono-
meric states. Ai states represent oligomers of i size, where i can take any
value from two to infinite. Fi represent oligomeric amyloid nuclei.
Double arrows indicate rapidly-equilibrated reversible processes and
the single arrow indicates a rate-limiting irreversible process.
doi:10.1371/journal.pone.0049690.g008
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Changes in the values of the rate constant of the conformational
change, kF, result only in a vertical displacement of the double
logarithmic plot. The effect of changes in the global unfolding
equilibrium constant, KU, is relatively small because it affects only
marginally the relative population of I and the corresponding
oligomerization equilibrium.
Using the equations of this model, we have fitted the
experimental initial rates of amyloid nucleation measured by
ThT fluorescence as a function of the protein concentration. In
this analysis we assumed that only the amyloid nuclei are detected
by thioflavin T fluorescence. An important problem arising when
fitting these data is that the theoretical equations depend on four
independent parameters (KA, KI, KU and kF). To reduce their
number, we fixed the values of KU using the experimental value at
37uC derived from the analysis of the thermal unfolding by DSC
at low protein concentration [23]. Another difficulty in this
analysis is that the interval of protein concentrations and the range
of experimentally accessible initial rates are limited. For instance,
at 50 mM NaCl, the fibril nucleation is fast only at high protein
concentrations, whereas below 1 mM the aggregation kinetics
shows a considerable lag phase [23]. The range of experimental
data is therefore quite limited for this condition.
Individual fits at the three different salt concentrations describe
very well the data but the dependency between the fitting
parameters is high. We found that the fits converge to similar
values for KA for the different NaCl concentrations and the three
sets of initial rates could be globally fitted using a common value
for this parameter (Figure 1b), which suggests that the association
equilibrium constant does not change much with the concentra-
tion of NaCl. The parameters resulting from this analysis are
shown in Table 2. The increase in salt concentration stabilizes the
amyloidogenic intermediate relative to the native and unfolded
states, thus increasing its population. The rate constant of the
conformational conversion of oligomers into amyloid nuclei is also
considerably increased with salt concentration.
To further validate our nucleation model, we studied the
aggregation kinetics of a double mutant of the Spc-SH3 domain
(N47A+K43A). The second mutation K43A destabilizes strongly
the native state. The far-UV CD spectrum indicates a partially
unfolded conformation (Figure S5a) and the DSC thermogram
obtained at a low protein concentration shows a weak and broad
unfolding transition (Figure S5b), consistent with a low structural
cooperativity. This double mutant forms fibrils much faster than
the single mutant N47A in the presence of 100 mM NaCl as
observed by TEM (results not shown). Initial rates of nucleation
were measured by ThT fluorescence (Figure 1b). Under these
conditions, there is a rapid growth of ThT fluorescence indicating
a fast formation of amyloid nuclei. The plot of log r0 vs log C0 has
a slope close to one over most of the concentration range explored.
This is consistent with a kinetic regime where the amyloid
nucleation takes place from the oligomers, i.e., C0..(KA?KI)
21.
In fact, DLS indicates that this double mutant domain forms
oligomers even at 15uC and at relatively low concentrations
(Figure S5c). SEC analysis at 37uC also shows a considerable
population of oligomers prior to the incubation and during the
very early times of the aggregation kinetics (Figure S5d). Fitting the
initial aggregation rates using our model yielded a considerably
higher KI for this mutant, mainly due to a strong destabilization of
the native state. We needed however to fix the KA value in this
fitting because the data did not contain enough information for an
accurate determination of all the fitting parameters (Table 2).
Nevertheless, these results strongly support the validity of our
model and its power to provide thermodynamic and kinetic data
characterizing the amyloid nucleation process.
Discussion
Here we have shown that amyloid fibrillation of the N47A Spc-
SH3 mutant domain takes place following apparent high-order
irreversible kinetics, as a result of oligomeric precursors preceding
the fibril nucleation event. This high-order kinetics is confirmed by
fitting of aggregation kinetics followed by 2D-NMR or near-UV
CD, which selectively monitor the concentration of native
monomers. On the other hand, the kinetics followed by far-UV
CD and ANS fluorescence show that partial unfolding of the
native protein involving secondary structure changes and the
exposure of hydrophobic patches takes place significantly faster
than nucleation and with lower apparent order. This implies that
these early conformational changes are, at least in part, associated
to the formation of the pool of oligomeric precursors themselves.
These oligomers are likely to be low-populated, unstable and
interconverting species. Formation of transient oligomeric inter-
mediates has been previously reported as a crucial event preceding
amyloid fibrillation in many proteins. For instance, oligomeric
intermediates formed at low pH above a critical concentration of
amyloid-beta 1–40 were proposed to have micellar properties and
be in equilibrium with the monomeric protein [28]. Using photo-
induced cross linking it was observed that the Abeta 1–40 peptide
undergoes a rapid oligomerization equilibrium involving mono-
mer, dimer, trimer, and tetramer during the pre-nucleation phase
of fibril assembly [8]. Insulin fibrillation takes also place by rapid
formation of soluble oligomers followed by a slower transition into
a second distinct class of oligomers that lead to amyloid fibrils [29].
Single-molecule fluorescence methods have also shown a rapid
and transient increase in the population of oligomeric species
during the early stages of PI3–SH3 aggregation [7]. These early
oligomers formed a highly heterogeneous size distribution. All
these studies and many others show common features for early
stages of amyloid formation: i) early oligomers are structurally
unstable and interconverting species with heterogeneous sizes; ii)
the oligomerization pre-equilibrates rapidly from the monomers
prior to the nucleation event; iii) the oligomers then convert into
amyloid structures, which is the rate limiting step in fibrillation.
These general characteristics are in good agreement with our
results and constitute the basis of the presented model of amyloid
nucleation.
To monitor the initial aggregation rates we selected deliberately
the conditions under which the conversion of native N47A Spc-
SH3 into fibrils takes place without a lag phase due to a rapid
formation of amyloid nuclei. The advantage of this approach is
Table 2. Fitting parameters derived from the analysis of initial







50 mM 0.071 (fixed) 246 6 50 0.0024 6 0.0010 2.0 6 3.6
100 mM 0.117 (fixed) 0.0058 6 0.0010 17.6 6 2.8
200 mM 0.165 (fixed) 0.0109 6 0.0018 38.7 6 7.3
N47A-K43A Spc-SH3
100 mM 0.495 (fixed) 246 (fixed) 0.036 6 0.010 34.6 6 7.8
aCalculated from the unfolding curves measured by DSC. Data of N47A Spc-SH3
were taken from reference [23].
doi:10.1371/journal.pone.0049690.t002
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that the earliest times of the kinetic traces followed by ThT
fluorescence are mainly sensitive to the nucleation event. Similar
lag-free aggregation kinetics was previously observed by Dobson
and coworkers [11] for the PI3-SH3 domain at pH 3.6, whereas
fibrillation showing a lag phase occurs at lower pH. These authors
invoked a ‘‘nucleated conformational conversion’’ mechanism to
explain their fibrillation kinetics in the absence of lag phase,
similar to that proposed here. This mechanism was previously
proposed for the prion protein Sup35 [9], which was reported to
form structurally fluid oligomeric complexes that appear to be
crucial intermediates in the de novo amyloid nucleation. Fibrillation
of b2-microglobulin into disordered worm-like fibrils or short rod-
like fibrils has also been shown to occur without a lag-phase by an
aggregation pathway, which is different to that of the relatively
rigid long-straight fibrils classically associated with amyloid [30].
The partitioning between these different competing pathways is
modulated by environmental conditions and occurs during the
earliest conformational and association phenomena, which direct
subsequent events leading to different types of aggregates.
Since the early work of Oosawa et al. [3] many theoretical
models to describe quantitatively the kinetics of protein aggrega-
tion have been proposed with the aim to obtain kinetic and
thermodynamic parameters characterizing the critical steps of the
process (see [5] for a comprehensive review). Models were
developed to fit the nucleation-dependent kinetic curves typical
of protein aggregation and were usually formulated with the
assumption of an aggregation nucleus of a specific size [6,31–33].
Recently, Roberts and coworkers have proposed a combined
Lumry-Eyring and Nucleated Polymerization (LENP) model
[6,34], in which the aggregation rates are considered slow
compared to the folding-unfolding equilibrium. They model the
nucleation event as a conformational rearrangement of x-sized
oligomers into x-sized nuclei. Interestingly, by exploring different
qualitative kinetic regimes, they showed that their model is a
generalization of many previously proposed nucleation and growth
models for aggregation. One of their main findings is that under
the scenarios where nucleation is fast, the apparent kinetics of
monomer depletion follows x-order kinetics. Our finding of high
order kinetics is in agreement with the predictions of the LENP
model, which supports the validity of our assumption of fast
nucleation. Apparent sizes of the dominant amyloid nuclei ranging
between 3 and 6 molecules would be derived from the apparent
order of the kinetics depending on the conditions.
In spite of this agreement, our nucleation model does not imply
any assumption of a specific size for the aggregation nuclei. In fact,
we model the nucleation event as a conformational change taking
place within any preformed oligomer irrespective of their size. The
size distribution of the oligomers is however controlled by the
thermodynamic parameters of the process, i.e., the stability of the
amyloidogenic intermediate, the equilibrium constant for the
oligomerization and the protein concentration.
In a recent work, Vitalis and Pappu [35] have reanalyzed the
aggregation mechanism of polyglutamine peptides using a model
that also accounts for the possibility of nucleation from a pool of
heterogeneous oligomers, similarly to the model proposed here.
They clarified previous observations of fractional and/or negative
values of estimates of the critical nucleus size arising from the
assumption of a homogeneous nucleation model. The model
proposed by these authors for early aggregation shares with the
nucleation model proposed here two major assumptions: First, a
rapidly pre-equilibrated distribution of oligomers is formed by
successive monomer addition; second, the nucleation event occurs
by a rate-limiting conformational conversion of oligomers into pre-
fibrillar species. On the other hand, there are several mathematical
and conceptual differences between the two models: Vitalis and
Pappu do not analyze the initial aggregation rates but they adapt
their model to the analysis of early aggregation kinetics as
originally developed by Ferrone [33], in which they analyze the
slope of extent of aggregation plotted versus t2. They also take into
account the elongation of the fibrillar aggregates via monomer
addition, whereas we neglected its contribution in our model as
discussed above and in Text S3 of the Supporting Information. In
addition, these authors limited in their analysis the maximum
oligomer size and the minimum size of oligomers that are
competent for conformational conversion. Finally, they do not
consider the existence of a folding-unfolding equilibrium for the
monomer.
In spite of these differences, some of their fundamental
conclusions are similar to ours. They highlight the importance of
the factors controlling the oligomer distribution in determining the
apparent oligomer size in the analysis of the kinetics is made
assuming a single nucleus size. In particular, if the process
nucleates under conditions where large fractions of the aggregating
material are present as soluble oligomers that are competent to
promote fibril formation, then the apparent nucleus size may
results in quite anomalous values (fractional or even negative in
their analysis).In fact, using the equations of the model and the
parameters of Table 2, we could calculate the average size and the
size distributions of the pre-equilibrated oligomers for each
concentration of protein (see Figure S6). It is evident that the
size of the oligomers and their population depend quite
dramatically on the total protein concentration. At low concen-
trations there are mainly dimers at very low populations. As
concentration increases, the overall oligomer population increases
and the size distributions become shifted toward larger sizes and
considerably broadened. An increase in the NaCl concentration
strongly enhances oligomerization. Importantly, the experimental
order of the kinetics does not need to be correlated with the
average oligomer size, except if the measurements are made near
the critical concentration. For instance, at 50 mM NaCl concen-
tration, the N47A Spc-SH3 mutant shows an apparent order of
6.4, which is in very good agreement with the average sizes of the
oligomers predicted by our model (between 4 and 8 in the protein
concentration interval explored) but, despite this coincidence, the
size distributions are quite broad at these protein concentrations.
In contrast, the kinetics of the K43A-N47A double mutant were
studied well above its critical concentration and even though the
aggregation nucleates from a wide variety of oligomer sizes the
experimental order is close to one. The observation of concentra-
tion-independent nucleation at high protein concentration appears
to be a general property of polymerization models due to the fact
that under this regime the nuclei are no longer the least
thermodynamically unstable species, as described by Powers and
Powers [36].
The direct detection of the oligomeric precursors of nucleation
has proved extremely difficult, due to their instability and the fact
that they are not usually the dominant species in the aggregating
solution. Here we used DLS and SEC to analyze the mixtures
during the course of the aggregation. DLS shows the formation of
oligomeric particles with average hydrodynamic radii of about 2.7
to 3.0 nm and SEC is also able to detect a low population of
oligomeric species at early aggregation times but only when the
samples were analyzed at 37uC and at very high protein
concentrations. In contrast, the oligomers are clearly present for
the K43A-N47A double mutant even prior to aggregation, as
demonstrated by DLS and SEC. It is likely, however, that the
oligomer fraction detected during aggregation includes also stable
amyloid nuclei, which would not dissociate during the SEC
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analysis. Nevertheless, the existence of this range of oligomeric
species is fully consistent with the observed aggregation kinetics.
The possibility of nucleation from oligomers of different sizes,
which are modulated by the experimental conditions, could have
profound implications in understanding the mechanism of amyloid
aggregation. This is schematically illustrated in Figure 9. The
conformational conversion of the polypeptide chain into amyloid
structure may be constrained differently within oligomers of
different sizes, giving rise to a structural variability in the nuclei
and a consequent polymorphism of the final amyloid structures
modulated by the conditions [23,30,37]. Also, the amount and size
distribution of nucleating oligomers would affect strongly all
subsequent fibrillation stages. Conditions disfavoring oligomeriza-
tion, such as low salt or low protein concentration, would promote
a slower nucleation via smaller oligomers. As a consequence, less
abundant and more homogeneous nuclei would preferentially
grow via monomer addition into more ordered filaments that
could then assemble into mature twisted fibrils. On the other
hand, rapid accumulation of a heterogeneous distribution of
amyloid nuclei could promote aggregation via condensation or
growth of heterogeneous fibrils via monomer addition to a
diversity of structural templates, in any of these cases giving rise
to more disordered fibrillar aggregates [11] or even amorphous
aggregates as we observe for N47A Spc-SH3 in the presence of
300 mM NaCl (results not shown).
An important advantage of our kinetic approach is its
mathematical and experimental simplicity. The measurement of
initial aggregation rates are relatively straightforward and do not
need the recording of long aggregation kinetics, allowing the
exploration of a larger number of experimental variables. Also, the
equations describing the initial rates are very simple and
complicated numerical integration procedures are not necessary
to fit the data. This method could be applicable to any protein
aggregation process as long as the kinetics does not show a lag
phase and the initial rates are representative of the formation of
the earliest amyloid structures.
Our analysis provides important thermodynamic and kinetic
magnitudes allowing us to rationalize the nucleation event. This is
of chief importance to understand the factors governing the
stability of early amyloidogenic species. The amyloidogenic
monomeric intermediate of N47A Spc-SH3 is a very unstable
state, likely an ensemble of partially unfolded species. Its stability is
much lower even than the fully unfolded state under the
aggregation conditions. It has however a very strong propensity
to oligomerize, as indicated by the large association constant KA.
As a result, the concentration of I is very low under all conditions,
but the factors affecting its stability are key to modulate the
amount and distribution of oligomers that are competent to
nucleate aggregation. This is crucial to understand the mecha-
nisms by which proteins maintain solubility and avoid deleterious
aggregation processes. Protein sequences have evolved to maintain
a high structural cooperativity of the native states, favoring either
the native or the globally unfolded state under all conditions and
reducing the population of aggregation-prone partially unfolded
species. A reduction in the global unfolding cooperativity
produced by mutations has been shown to enhance amyloido-
genicity [38].
Our kinetic approach could be also relevant for the case of
intrinsically disordered proteins, such as Abeta or a-synuclein,
because their most populated soluble states are not necessarily the
amyloidogenic ones. It has been shown that disordered polypep-
tide chains must partially refold to initiate amyloid aggregation
[39] achieving a high-energy, partially-folded conformation, which
then is able to oligomerize and aggregate. This is similar to what
we observed for the double mutant K43A-N47A Spc-SH3. The
soluble monomeric state is probably an ensemble of conformations
with low unfolding cooperativity but the amyloidogenic confor-
mation does not need to be the most populated one but just a
subfraction of this ensemble.
Another important result is that an increase in the NaCl
concentration appears to produce a selective stabilization of the
monomeric intermediate, I, and not an enhancement of its
association tendency. NaCl also increases the rate constant of the
conformational conversion to amyloid structure. Salt ions may
affect protein aggregation by a number of mechanisms but how
each specific molecular stage is influenced by ions is still not
known. Simple Debye-Hückel screening of electrostatic interac-
tions has been ruled out as a main contributor to aggregation for
Figure 9. Simplified model of amyloid fibril nucleation. Schematic illustration based on the results of this work of how the environmental
conditions could modulate the mechanism amyloid nucleation. Non-amyloid partially-unfolded molecules and oligomers are represented in orange,
whereas amyloid nuclei and fibrils are represented in blue. Top and bottom electron micrographs correspond respectively to twisted-straight amyloid
fibrils and curly fibrils of N47A Spc-SH3 obtained under different conditions of nucleation.
doi:10.1371/journal.pone.0049690.g009
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several systems [40,41], although it plays a role on fibrillation of a-
synuclein at low ionic strengths [42]. Preferential anion binding to
the protein groups has been proposed as a main mechanism
promoting fibrillation of b2-microglobulin at acid pH, because the
aggregation enhancement produced by different ions is ordered
according to the electroselectivity series [43]. Similar observations
were made for the fibrillation of glucagon [40] and mouse prion
protein [44] both at acid pH. In contrast, the effect of ions on a-
synuclein fibrillation has been found to follow the Hofmeister
series, suggesting an important role of hydration effects [42]. The
aggregation of Abeta1–40 at pH 9 seems to depend on a
combination of both effects [41]. The result of our analysis
ascribes the effect of salt ions mainly to a relative stabilization of
the amyloidogenic monomer, which is partially unfolded and
exposes a significant amount of hydrophobic surface. Also, at the
mildly acid pH of our experiments the protein is positively
charged. At the relatively low NaCl concentrations used in these
experiments and given that the Na+ and Cl2 ions are neither
strong ‘‘salting-out’’ or ‘‘salting-in’’ ions [45], it is unlikely that the
intermediate is primarily stabilized by a Hofmeister effect. In fact,
the fully unfolded state exposing more surface area is less stabilized
by NaCl than the intermediate. Preferential binding of chloride
anions to the intermediate relative to the native state could be
playing a role in compensating the net positive charge, reducing
electrostatic repulsion and thus favoring oligomerization. A more
profound investigation of the effect of different salt ions is however
necessary to clarify these effects.
Conclusions
We have shown that the amyloid nucleation kinetics of the Spc-
SH3 domain obeys to a high-order irreversible kinetics. The
analysis of the aggregation kinetics by a variety of biophysical
methods has allowed us to infer that the earliest stages of the
amyloid nucleation process imply a pre-equilibrium involving
oligomerization of a partially-unfolded intermediate followed by a
conformational conversion of the polypeptide chain within the
oligomers. The latter process leads to formation of the amyloid
nuclei. A simple mathematical model can account very well for the
experimental initial rates of aggregation and their dependence
with the concentration of protein. The model has allowed us to
derive thermodynamic magnitudes characterizing the highly
unstable amyloidogenic intermediate and its oligomers. It is shown
that environmental conditions such as protein or salt concentra-
tion can strongly affect the stability and population of the
precursors, leading to different nucleation scenarios that may in
turn result in diverse aggregation pathways and fibril morpholo-
gies. The kinetic approach presented here may be applicable to
characterize the amyloidogenic intermediates and oligomeric
precursors of amyloid aggregation in disease-related proteins.
Supporting Information
Figure S1 Linearity of the thioflavine T (ThT) fluores-
cence as a function of the concentration of amyloid
fibrils. Amyloid fibrils of N47A mutant of the Spc-SH3 were
prepared by in incubation at 37uC in 100 mM glycine buffer,
100 mM NaCl pH 3.2, isolated by centrifugation and resuspended
in the same buffer for ThT assay.
(PDF)
Figure S2 Near-UV CD spectra of N47A Spc-SH3 in the
native state and the amyloid fibrillar state. Spectra were
recorded at the same protein concentration at 25uC in 100 mM
glycine buffer, 100 mM NaCl pH 3.2.
(PDF)
Figure S3 Infrared spectra of N47A Spc-SH3 recorded
during the aggregation at 376C. Buffer was 100 mM glycine
buffer, 100 mM NaCl pH 3.2 and the protein concentration was
1.59 mM.
(PDF)
Figure S4 Overlay of 15N-1H HSQC NMR spectra of
N47A Spc-SH3 at different times of aggregation at 376C.
Buffer conditions were the same as in Figure S3, except for the use
of per-deuterated glycine and the addition of 10% D2O for field
lock. The concentration of 15N-labelled protein was 1.1 mM
(8 mg mL21). The three spectra have been plotted using a single
contour level and the same intensity threshold. The times of
incubation are: 3 min (blue); 50 min (green) and 1957 min (red).
The numbers next to each cross-peak indicate the residue number
assignment.
(PDF)
Figure S5 Structure, stability and oligomerization state
of the K43A-N47A Spc-SH3 double mutant. a) Far-UV CD
spectrum in comparison with the N47A single mutant; b) thermal
unfolding monitored by DSC; c) Apparent hydrodynamic radius
determined at 15uC at different concentrations as indicated. The
vertical dashed line indicates the radius of the native Spc-SH3
domain; d) Size-exclusion chromatography at 37uC at two
different concentrations as indicated. The peak eluting at ca.
20 mL corresponds to the monomer and the excluded volume is
about 8.5 mL.
(PDF)
Figure S6 Simulations of oligomer size distributions.
Average size distributions were calculated using the parameters
derived from the fitting of the experimental initial rates using the
equations of the model (see main manuscript text). (a) Average size
of the oligomers as a function of the total protein concentration; (b)
Average size of all the particles present in solution; (c) Size
distribution of the oligomers at 1 mM of total protein concentra-
tion; (d) Size distribution of the oligomers at the critical
concentration, (KA?KI)
21, obtained under each experimental
condition.
(PDF)
Text S1 Model of amyloid nucleation preceded by
partial unfolding and oligomerization pre-equilibrium.
(PDF)
Text S2 Model simulations.
(PDF)
Text S3 Contribution of fibril elongation by monomer
addition to the early kinetics.
(PDF)
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